Correlation Between Conduit Pharmaceuticals and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Conduit Pharmaceuticals and Novo Nordisk AS, you can compare the effects of market volatilities on Conduit Pharmaceuticals and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and Novo Nordisk.
Diversification Opportunities for Conduit Pharmaceuticals and Novo Nordisk
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Conduit and Novo is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and Novo Nordisk go up and down completely randomly.
Pair Corralation between Conduit Pharmaceuticals and Novo Nordisk
Assuming the 90 days horizon Conduit Pharmaceuticals is expected to generate 17.58 times more return on investment than Novo Nordisk. However, Conduit Pharmaceuticals is 17.58 times more volatile than Novo Nordisk AS. It trades about 0.12 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.02 per unit of risk. If you would invest 7.00 in Conduit Pharmaceuticals on August 27, 2024 and sell it today you would lose (5.51) from holding Conduit Pharmaceuticals or give up 78.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 55.85% |
| Values | Daily Returns |
Conduit Pharmaceuticals vs. Novo Nordisk AS
Performance |
| Timeline |
| Conduit Pharmaceuticals |
| Novo Nordisk AS |
Conduit Pharmaceuticals and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Conduit Pharmaceuticals and Novo Nordisk
The main advantage of trading using opposite Conduit Pharmaceuticals and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Conduit Pharmaceuticals vs. Eliem Therapeutics | Conduit Pharmaceuticals vs. HCW Biologics | Conduit Pharmaceuticals vs. Scpharmaceuticals | Conduit Pharmaceuticals vs. Milestone Pharmaceuticals |
| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |